feed,title,long_url,short_url
Benzinga,"The global radioligand therapy market was valued at $9,754.9 million in 2020 and is expected to reach $16,658.4 million by 2031, witnessing a CAGR of 4.67% during the forecast period 2021-2031",https://benzinga.com/pressreleases/22/03/g26390337/the-global-radioligand-therapy-market-was-valued-at-9-754-9-million-in-2020-and-is-expected-to-rea,
